Influence of different ex vivo cell culture methods on the proliferation and anti-tumor activity of cytokine-induced killer cells from gastric cancer patients

References

• McGuireSWorld Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015Adv Nutr20167241841926980827
   PubMed Web of Science ®Google Scholar
• MuYWangWHXieJPZhangYXYangYPZhouCHEfficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized phase II studyOnco Targets Ther201694617462727524915
   PubMed Web of Science ®Google Scholar
• MuYZhouCHChenSFEffectiveness and safety of chemotherapy combined with cytokine-induced killer cell/dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: a systematic review and meta-analysisCytotherapy20161891162117727421742
   PubMed Web of Science ®Google Scholar
• HanRXLiuXPanPJiaYJYuJCEffectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysisPLoS One201499e10895825268709
   PubMed Web of Science ®Google Scholar
• ZhangZWangLLuoZEfficacy and safety of cord blood-derived cytokine-induced killer cells in treatment of patients with malignanciesCytotherapy20151781130113825963952
   PubMed Web of Science ®Google Scholar
• DahlbergCISarhanDChrobokMDuruADAliciENatural killer cell-based therapies targeting cancer: possible strategies to gain and sustain anti-tumor activityFront Immunol2015660526648934
   PubMed Web of Science ®Google Scholar
• WangYXuZZhouFThe combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumorsExp Hematol Oncol201543226561538
   PubMedGoogle Scholar
• ShiLZhouQWuJEfficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancerCancer Immunol Immunother201261122251225922674056
   PubMed Web of Science ®Google Scholar
• ZhaoLLvMSayimuWTherapeutic effect of lymphokine-activated killer cells treated with low-dose ionizing radiation on osteosarcomaOncol Lett201510287988226622587
   PubMed Web of Science ®Google Scholar
• LinTSongCChuoDYZhangHZhaoJClinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective studyTumour Biol20163744367437226499782
   PubMedGoogle Scholar
• MehtaBASchmidt-WolfIGWeissmanILNegrinRSTwo pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cellsBlood1995869349334997579455
   PubMed Web of Science ®Google Scholar
• WangYLvBLiKZhangALiuHAdjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trialsDrug Des Devel Ther20171132453256
   Web of Science ®Google Scholar
• LiGXZhaoSSZhangXGComparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitroMol Med Rep20151222629263525955083
   PubMed Web of Science ®Google Scholar
• GuoYHanWCytokine-induced killer (CIK) cells: from basic research to clinical translationChin J Cancer20153439910725962508
   PubMedGoogle Scholar
• GaoXMiYGuoNCytokine-induced killer cells as pharmacological tools for cancer immunotherapyFront Immunol2017877428729866
   PubMed Web of Science ®Google Scholar
• PanKWangQJLiuQThe phenotype of ex vivo generated cytokine-induced killer cells is associated with overall survival in patients with cancerTumour Biol201435170170723955802
   PubMed Web of Science ®Google Scholar
• LiuHLiJWangFComparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinomaTumour Biol20153642299230725417201
   PubMedGoogle Scholar
• SiegelILiuTLGleicherNThe red-cell immune systemLancet1981282465565596116004
   PubMed Web of Science ®Google Scholar
• SilvaALopez-BotetMAlvarezJde LandazuriMOEnhancement of the functional activities of human T cells after their interaction with SRBCJ Immunol198112623933976450242
   PubMed Web of Science ®Google Scholar
• ArosaFAPereiraCFFonsecaAMRed blood cells as modulators of T cell growth and survivalCurr Pharm Des200410219120114754398
   PubMed Web of Science ®Google Scholar
• JyonouchiHKincadePWMisraHPAnalysis of the effects of erythrocytes on mitogen-dependent clonal proliferation of murine B lymphocytesCell Immunol19848311891986607124
   PubMed Web of Science ®Google Scholar
• RugelesMTLa ViaMGoustJMKilpatrickJMHymanBVirellaGAutologous red blood cells potentiate antibody synthesis by unfractionated human mononuclear cell culturesScand J Immunol19872621191273114872
   PubMed Web of Science ®Google Scholar
• YannelliJRThurmanGBMrowca-BastinAPenningtonCSWestWHOldhamRKEnhancement of human lymphokine-activated killer cell cytolysis and a method for increasing lymphokine-activated killer cell yields to cancer patientsCancer Res19884820569657003262411
   PubMed Web of Science ®Google Scholar
• ShauHGuptaRKGolubSHIdentification of a natural killer enhancing factor (NKEF) from human erythroid cellsCell Immunol199314711118462106
   PubMed Web of Science ®Google Scholar
• MoscaTForteWCComparative efficiency and impact on the activity of blood neutrophils isolated by percoll, Ficoll and spontaneous sedimentation methodsImmunol Invest2016451293726699845
   PubMed Web of Science ®Google Scholar
• OliosoPGiancolaRDi RitiMContentoAAccorsiPIaconeAImmunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trialHematol Oncol200927313013919294626
   PubMed Web of Science ®Google Scholar
• LeeJHLimYSYeonJEAdjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinomaGastroenterology201514871383139125747273
   PubMed Web of Science ®Google Scholar
• LinnYCNiamMChuSThe anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignanciesBone Marrow Transplant201247795796621986635
   PubMed Web of Science ®Google Scholar
• IntronaMPievaniABorleriGFeasibility and safety of adoptive immunotherapy with CIK cells after cord blood transplantationBiol Blood Marrow Transplant201016111603160720685246
   PubMed Web of Science ®Google Scholar
• IntronaMBorleriGContiERepeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I studyHaematologica200792795295917606446
   PubMed Web of Science ®Google Scholar
• LeemhuisTWellsSScheffoldCEdingerMNegrinRSA phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphomaBiol Blood Marrow Transplant200511318118715744236
   PubMed Web of Science ®Google Scholar
• ZhangZZhaoXZhangTPhenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord bloodCytotherapy2015171869725457278
   PubMed Web of Science ®Google Scholar
• TarnvikARed cells erythroagglutinating activity of phytohaemagglutinin, and lymphocyte stimulationActa Pathol Microbiol Scand B Microbiol Immunol19717956356405286214
   PubMedGoogle Scholar
• FonsecaAMPortoGUchidaKArosaFARed blood cells inhibit activation-induced cell death and oxidative stress in human peripheral blood T lymphocytesBlood200197103152316011342443
   PubMed Web of Science ®Google Scholar
• KalechmanYHermanSGafterUSredniBEnhancing effects of autologous erythrocytes on human or mouse cytokine secretion and IL-2R expressionCell Immunol199314811141298098664
   PubMed Web of Science ®Google Scholar
• HamannDRoosMTvan LierRAFaces and phases of human CD8 T-cell developmentImmunol Today199920417718010203715
   PubMedGoogle Scholar
• FonsecaAMPereiraCFPortoGArosaFARed blood cells promote survival and cell cycle progression of human peripheral blood T cells independently of CD58/LFA-3 and heme compoundsCell Immunol20032241172814572797
   PubMed Web of Science ®Google Scholar
• TaoQWangHZhaiZTargeting regulatory T cells in cytokine-induced killer cell cultures (review)Biomed Rep20142331732024748966
   PubMedGoogle Scholar
• ToveyMGLallemandCAdjuvant activity of cytokinesMethods Mol Biol201062628730920099135
   PubMedGoogle Scholar
• SimGCRadvanyiLThe IL-2 cytokine family in cancer immunotherapyCytokine Growth Factor Rev201425437739025200249
   PubMed Web of Science ®Google Scholar
• YangJCSherryRMSteinbergSMRandomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancerJ Clin Oncol200321163127313212915604
   PubMed Web of Science ®Google Scholar
• ZhangQWangLLuoCPhenotypic and functional characterization of cytokine-induced killer cells derived from preterm and term infant cord bloodOncol Rep20143252244225225176036
   PubMed Web of Science ®Google Scholar
• BateCAKwiatkowskiDPStimulators of tumour necrosis factor production released by damaged erythrocytesImmunology19948322562617835944
   PubMed Web of Science ®Google Scholar
• DaiCLinFGengRImplication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancerOncotarget201679103321034426871284
   PubMedGoogle Scholar
• LiuLWYangMYZhouMLiJJLiuBPanYYImprovement of cytotoxicity of autologous CIKs from patients with breast cancer to MCF-7 cells by suppressed PD-1 expressionCancer Biomark201720460961528869441
   PubMed Web of Science ®Google Scholar
• PohSLLinnYCImmune checkpoint inhibitors enhance cytotoxicity of cytokine-induced killer cells against human myeloid leukaemic blastsCancer Immunol Immunother201665552553626961084
   PubMed Web of Science ®Google Scholar